B
BMY icon

Brightworth’s Bristol-Myers Squibb BMY Stock Holding History

Brightworth’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,487
Closed -$716K – 121
2021
Q4 		$716K Buy
11,487
+2,292
+25% +$134K 0.07% 75
2021
Q3 		$544K Buy
9,195
+473
+5% +$31.1K 0.05% 75
2021
Q2 		$583K Buy
8,722
+132
+2% +$8.61K 0.05% 66
2021
Q1 		$542K Buy
8,590
+1,078
+14% +$67.1K 0.05% 66
2020
Q4 		$466K Buy
7,512
+1,428
+23% +$87.8K 0.05% 67
2020
Q3 		$367K Buy
6,084
+1,404
+30% +$84.5K 0.04% 70
2020
Q2 		$275K Buy
+4,680
New +$280K 0.04% 70
2018
Q2 		– Sell
-3,426
Closed -$217K – 97
2018
Q1 		$217K Sell
3,426
-159
-4% -$10.2K 0.05% 113
2017
Q4 		$220K Sell
3,585
-67
-2% -$4.19K 0.05% 111
2017
Q3 		$233K Buy
+3,652
New +$213K 0.06% 112

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Brightworth's BMY Position: Q1 2022 in Review

Brightworth sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 11,487 shares — an estimated $716K sold.

Brightworth first reported a position in BMY in Q3 2017 and held it in 10 quarters. The position peaked at $716K in Q4 2021. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.

  • Brightworth reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
  • Brightworth sold 11,487 Bristol-Myers Squibb shares in Q1 2022, an estimated $716K.
  • Brightworth first reported a position in Bristol-Myers Squibb in Q3 2017 and held it in 10 quarters.
  • Brightworth's Bristol-Myers Squibb position peaked at $716K in Q4 2021.
  • 2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.

Based on Brightworth's 13F filing for Q1 2022, filed 29 Apr 2022.